Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials.
Saved in:
| Title: | Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials. |
|---|---|
| Authors: | Fulcher, Greg1 greg.fulcher@sydney.edu.au, Mehta, Roopa2, Fita, Edmond G.3, Ekelund, Magnus3, Bain, Stephen C.4 |
| Source: | Diabetes Therapy. Feb2019, Vol. 10 Issue 1, p107-118. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
